Could another possible reason for the speedy settlement be that GSK are looking to licence LANI?
It makes sense, a possible billion dollar deal for Biota/Sankyo that is currently being held back by the Relenza litigation?!?!?!?
Any thoughts?
- Forums
- ASX - By Stock
- up from here
Could another possible reason for the speedy settlement be that...
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)